Oxyntomodulin peptide analogue

Details for Australian Patent Application No. 2010341650 (hide)

Owner Eli Lilly and Company

Inventors Alsina-Fernandez, Jorge; Kohn, Wayne David

Agent Spruson & Ferguson

Pub. Number AU-A-2010341650

PCT Pub. Number WO2011/087671

Priority 61/352,569 08.06.10 US; 61/288,884 22.12.09 US

Filing date 15 December 2010

Wipo publication date 21 July 2011

International Classifications

C07K 14/605 (2006.01) Peptides having more than 20 amino acids

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 38/26 (2006.01) Medicinal preparations containing peptides - Glucagons

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

7 June 2012 PCT application entered the National Phase

  PCT publication WO2011/087671 Priority application(s): WO2011/087671

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010341651-Oxyntomodulin peptide analogue

2010341649-Use of porous nonwoven scrims in acoustical panels